SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-125512
Filing Date
2020-11-16
Accepted
2020-11-16 09:40:00
Documents
6
Period of Report
2020-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2036007d1_6k.htm 6-K 13968
2 EXHIBIT 99.1 tm2036007d1_ex99-1.htm EX-99.1 57586
3 EXHIBIT 99.2 tm2036007d1_ex99-2.htm EX-99.2 8181
4 GRAPHIC image_001.jpg GRAPHIC 173903
5 GRAPHIC image_002.jpg GRAPHIC 754884
6 GRAPHIC image_003.jpg GRAPHIC 3887
  Complete submission text file 0001104659-20-125512.txt   1365890
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 201314224
SIC: 2834 Pharmaceutical Preparations